PRESS RELEASE
FOR IMMEDIATE RELEASE
THE DARK REPORT
21806 Briarcliff Dr.
Spicewood, TX 78669
512-264-7103 o
512-264-0969 f
Media Contact: Bill Sinagra
info@darkreport.com
Free Webinar: Pharmacogenomics: Leveraging Capacity to Expand Your Molecular Laboratory Capabilities
AUSTIN, TEXAS (September 29, 2022) – A new, free Dark Daily webinar will help laboratories discover how to expand into pharmacogenomics (PGx) and learn about the importance of genetics and laboratory services in medication management.
Pharmacogenomics has immense potential in the routine clinical testing space, but there are many considerations to PGx adoption and scalability within the laboratory. During the 1pm EDT October 26 webinar, Pharmacogenomics: Leveraging Capacity to Expand Your Molecular Laboratory Capabilities, Jeff Shaman, PhD, MS, Chief Science Officer of Coriell Life Sciences will discuss why pharmacogenomics matters and how the COVID health crisis has created unprecedented capacity and acceptance for PGx in laboratory testing.
Up-and-coming and seasoned lab leaders will learn how laboratory technology, science, implementation models, and economic proof points have all achieved deployable maturity for PGx labs. Most importantly, the program will define the stages of PGx laboratory implementation maturity and key success points for expanding your laboratory’s PGx testing capability.
For more information and to register for this free one-hour program, sponsored by Thermo Fisher Scientific, click here. Can’t make the live program? Register anyway to receive a link to stream the program on demand after the webinar.
About The Dark Intelligence Group
Since 1995, The Dark Intelligence Group (TDIG), publisher of The Dark Report which produces the Executive War College, has been the clinical laboratory industry’s pre-eminent source for essential market intelligence and business news. It provides strategic information and training to independent lab companies, hospitals and health systems, and pathology group practices. TDIG also offers access to IVD companies seeking to get their solutions in front of our large and loyal list of clinical lab and pathology executives through actionable, relevant and high-quality content vehicles and networking opportunities..
-end-